Navigation Links
Medical Marijuana Inc. Announces Ted Caligiuri as Interim President and CEO
Date:9/18/2012

SAN DIEGO, Sept. 18, 2012 /PRNewswire/ -- Medical Marijuana Inc. (OTC: MJNA), a leading hemp industry innovator, is pleased to formally announce the appointment of Ted Caligiuri as Interim President and CEO, taking over day-to-day operations from Michael Llamas who announced his leave of absence for personal business reasons.

Mr. Caligiuri has served on the Board of the Company since shortly after the acquisition of MJNA by CannaBank in early 2011. For the past two years, he has been actively involved and instrumental in a number of areas of the company, such as helping with compliance related matters, working with management to complete its 15c2-11 filing and prepare for eventual up-listing, evaluating audit and compliance firms, as well as assisting with operational issues surrounding the Company's Hemp-based CBD production.

"Given his broad expertise and heavy involvement over the past two years, Ted was a natural choice to step in and execute a smooth transition," stated Michelle Sides, Chairman of the Board. "His industry knowledge and business guidance will be an invaluable part of our company's strong growth as we move forward with Dixie X and CanChew product launches and our many other exciting developments."

A Southern California native, Mr. Caligiuri is an accomplished leader and MJNA shareholder with over 25 years of business management experience. He is known in the San Diego community not only for his business leadership, but for his involvement in several charitable organizations including the YMCA. His professional experience includes work as a management consultant and technology consultant.  As a management consultant, he assisted companies in managing growth and streamlining operations.  As a technology consultant, he assisted companies in the identification and proprietary control of technologies for new products, including the commercialization of NASA developed technologies.  In 1991, he founded an environmental product company targeted at reducing waste by enhancing the convenience of re-usable shopping bags.  In this role, Mr. Caligiuri invented and patented new consumer-focused shopping bag concepts. In the early 2000's he was the Chief Operating Officer of an ergonomic writing instrument company and was responsible for doubling sales and filing 6 patents over the course of 2 years. Currently, he works as a Real Estate Consultant for Coldwell Banker Commercial.

"I look forward to continuing to work closely with Ted, a person of high integrity and personal character, as well as our senior management team. It's an especially exciting time for our company as we roll-out our Dixie X line of CBD wellness products," says Tripp Keber, President, Red Dice Holdings.

"I appreciate the confidence that the Board placed in me to fill the void left by Michael's departure. MJNA has assembled an incredible team and an equally incredible line of revenue producing products. More importantly, we have the opportunity to help millions of people experience the benefits of our revolutionary CBD wellness products. My initial focus will be to successfully complete our 15c2-11 filing, our audits and ultimately our up-listing, as well as close the current financing transactions that continue to progress positively at this point. I look forward to working with our team to continue the success of MJNA," says Ted Caligiuri, Interim President and CEO of Medical Marijuana, Inc.

About Medical Marijuana, Inc.

Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally friendly, economically sustainable businesses, while increasing shareholder value.

Medical Marijuana Inc. does not grow, sell or distribute any substances that violate United States Law or the controlled substance act.

For more information, please visit the company's website at:

www.MedicalMarijuanaInc.com

FORWARD-LOOKING DISCLAIMER

This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.

FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the Food and Drug Administration (FDA). These products and statements are not intended to diagnose, treat, cure, or prevent any disease.

Corporate Contact:

Medical Marijuana, Inc.
Toll Free: 888-OTC-MJNA (888-682-6562)
www.medicalmarijuanainc.com
www.facebook.com/mjnainc

Investor Relations Contact:

Stuart T. Smith
SmallCapVoice.Com, Inc.
P. 512-267-2430
F. 512-267-2530
Email: ssmith@smallcapvoice.com
Skype: SmallCapVoice.com
AIM: SmallCapVoice7


'/>"/>
SOURCE Medical Marijuana Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. San Diego Medical Device Developers - Network at MEDevice San Diego This Week
2. Sequent Medical, Inc. Awarded U.S. Patent for MicroBraid Technology
3. DiFUSION Technologies Announces Breakthrough Medical Polymer
4. Haemonetics Provides Update on Hemerus Medical, LLC Acquisition
5. Medical Alarm Concepts Publishers Shareholder Letter
6. Varian Medical Systems Publishes 2012 Sustainability Report Outlining Environmental, Charitable, Safety and Health Access Achievements
7. Putnam Community Medical Center Selects Optimal Radiology
8. Call for Papers: MD&M West 2013 Conference for Medical Device Design and Manufacturing
9. Living with Knee Pain? Adventist Medical Center Offers New Treatment Option
10. Study Published In Contraception Evaluates Medical Expenditures For Unintended Pregnancies And Potential Cost Impact Of Increased Use Of Long-Acting Reversible Contraception
11. Emmaus Medical Marks Progression of Phase 3 Sickle Cell Disease Clinical Trial During Sickle Cell Awareness Month
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... , April 20, 2017  Zimmer Biomet Holdings, Inc. ... healthcare, today announced that it will be participating in ... at the InterContinental Hotel in Boston, Massachusetts ... will present at 11:20 a.m. Eastern Time. ... via Zimmer Biomet,s Investor Relations website at http://investor.zimmerbiomet.com ...
(Date:4/20/2017)... 20, 2017  RXi Pharmaceuticals Corporation (NASDAQ: RXII), ... address significant unmet medical needs, today announced that ... consumer product development program, based on its proprietary ... Investigative Dermatology (SID) 76 th Annual Meeting.  ... the sciences relevant to skin health and disease ...
(Date:4/20/2017)... WOONSOCKET, R.I. , April 20, 2017 /PRNewswire/ ... (NYSE: CVS), today unveiled a new store design ... new assortment of healthier food, health-focused products and ... the store to help customers discover new offerings. ... represent the next evolution of the customer experience ...
Breaking Medicine Technology:
(Date:4/28/2017)... ... 2017 , ... Ushio America proudly introduces the new ... solution for F32T8 fluorescent lamps on most instant-start and programmed-start electronic ballasts so ... lamps utilize the existing electronic ballast, saving labor and maintenance costs. It’s easy ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... ... announce that Aditya Patel M.D. has joined the revolutionary endoscopic practice under Dr. ... board certification in Interventional Pain Medicine. The patented, revolutionary eDiscSculpt Technique created and ...
(Date:4/28/2017)... ... April 28, 2017 , ... The Texas Cord Blood Bank (TCBB), a program ... delivery team at Women’s Hospital at Renaissance in Edinburg for their outstanding efforts in ... and decide to donate. , “Women’s Hospital at Renaissance has been a collection ...
(Date:4/28/2017)... ... April 28, 2017 , ... Early ... substantially improve drug safety and minimize the cost of development. In this webinar, ... inhibition using cell lines and for cardiac toxicity using induced pluripotent stem cells ...
(Date:4/28/2017)... ... 2017 , ... Bill Howe started his sewer and drain company in 1980 ... joined the team, the Bill Howe brand was born and they began cultivating their ... back to the San Diego community in which they worked, lived and were raising ...
Breaking Medicine News(10 mins):